257 related articles for article (PubMed ID: 19852066)
1. Hemoglobin Hakkari: an autosomal dominant form of beta thalassemia with inclusion bodies arising from de novo mutation in exon 2 of beta globin gene.
Kanathezhath B; Hazard FK; Guo H; Kidd J; Azimi M; Kuypers FA; Vichinsky EP; Lal A
Pediatr Blood Cancer; 2010 Feb; 54(2):332-5. PubMed ID: 19852066
[TBL] [Abstract][Full Text] [Related]
2. Rare form of autosomal dominant thalassemia--hemoglobin Hakkari.
Nair S; Eldjerou LK; Harris NS; Dunbar LN
Pediatr Blood Cancer; 2014 Nov; 61(11):2118-20. PubMed ID: 24789613
[TBL] [Abstract][Full Text] [Related]
3. A deletion of 11 bp (CD 131-134) in exon 3 of the beta-globin gene produces the phenotype of inclusion body beta-thalassemia.
Ropero P; Villegas A; Martínez M; Ataulfo González Fernández F; Benavente C; Mateo M
Ann Hematol; 2005 Sep; 84(9):584-7. PubMed ID: 15977037
[TBL] [Abstract][Full Text] [Related]
4. Two missense mutations in the beta-globin gene can cause severe beta thalassemia. Hemoglobin Medicine Lake (beta 32[B14]leucine-->glutamine; 98 [FG5] valine-->methionine).
Coleman MB; Lu ZH; Smith CM; Adams JG; Harrell A; Plonczynski M; Steinberg MH
J Clin Invest; 1995 Feb; 95(2):503-9. PubMed ID: 7860732
[TBL] [Abstract][Full Text] [Related]
5. A novel beta-globin structural mutant, Hb Brescia (beta 114 Leu-Pro), causing a severe beta-thalassemia intermedia phenotype.
Murru S; Poddie D; Sciarratta GV; Agosti S; Baffico M; Melevendi C; Pirastu M; Cao A
Hum Mutat; 1992; 1(2):124-8. PubMed ID: 1301199
[TBL] [Abstract][Full Text] [Related]
6. Hb Filottrano [codon 120 (-A)]: a novel frameshift mutation in exon 3 of the β-globin gene causing dominantly inherited β-thalassemia intermedia.
Amato A; Cappabianca MP; Perri M; Zaghis I; Mastropietro F; Ponzini D; Di Biagio P; Piscitelli R
Hemoglobin; 2012; 36(5):480-4. PubMed ID: 22992010
[TBL] [Abstract][Full Text] [Related]
7. Distinct phenotypic expression associated with a new hyperunstable alpha globin variant (Hb heraklion, alpha1cd37(C2)Pro>0): comparison to other alpha-thalassemic hemoglobinopathies.
Traeger-Synodinos J; Papassotiriou I; Metaxotou-Mavrommati A; Vrettou C; Stamoulakatou A; Kanavakis E
Blood Cells Mol Dis; 2000 Aug; 26(4):276-84. PubMed ID: 11042028
[TBL] [Abstract][Full Text] [Related]
8. Dominantly Inherited beta-Thalassemia.
Efremov GD
Hemoglobin; 2007; 31(2):193-207. PubMed ID: 17486503
[TBL] [Abstract][Full Text] [Related]
9. Hb Florida: a novel elongated C-terminal beta-globin variant causing dominant beta-thalassemia phenotype.
Weinstein BI; Erramouspe B; Albuquerque DM; Oliveira DM; Kimura EM; Costa FF; Sonati MF
Am J Hematol; 2006 May; 81(5):358-60. PubMed ID: 16628732
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.
Darwish HM; El-Khatib FF; Ayesh S
Hemoglobin; 2005; 29(2):119-32. PubMed ID: 15921164
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation of -73(A-->T) in the CCAAT box of the beta-globin gene identified in a patient with the mild beta-thalassemia intermedia.
Chen XW; Mo QH; Li Q; Zeng R; Xu XM
Ann Hematol; 2007 Sep; 86(9):653-7. PubMed ID: 17516066
[TBL] [Abstract][Full Text] [Related]
12. A Novel Human β-Globin Gene Variant [Hb London-Ontario,
Bienz MN; Hsia C; Waye JS; Bode M; Solh Z
Hemoglobin; 2019 Mar; 43(2):129-131. PubMed ID: 31246535
[TBL] [Abstract][Full Text] [Related]
13. The genetic heterogeneity of β-globin gene defects in Sicily reflects the historic population migrations of the island.
Giambona A; Vinciguerra M; Cannata M; Cassarà F; Fiorentino G; Leto F; Gioco PL; Renda D; Passarello C; Maggio A
Blood Cells Mol Dis; 2011 Apr; 46(4):282-7. PubMed ID: 21353607
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of thalassemia intermedia in Iran.
Akbari MT; Izadi P; Izadyar M; Kyriacou K; Kleanthous M
Hemoglobin; 2008; 32(5):462-70. PubMed ID: 18932071
[TBL] [Abstract][Full Text] [Related]
15. Three new beta-thalassemia mutations with varying degrees of severity.
Frischknecht H; Dutly F; Walker L; Nakamura-Garrett LM; Eng B; Waye JS
Hemoglobin; 2009; 33(3):220-5. PubMed ID: 19657836
[TBL] [Abstract][Full Text] [Related]
16. A
Gürlek-Gökçebay D; Akpinar-Tekgunduz S; Erdem HB; Yarali N
Hemoglobin; 2019; 43(4-5):277-279. PubMed ID: 31530045
[TBL] [Abstract][Full Text] [Related]
17. Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India.
Colah R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Surve R; Subramaniam PG; Bondge N; Pujari K; Ghosh K; Mohanty D
Blood Cells Mol Dis; 2004; 33(2):153-7. PubMed ID: 15315795
[TBL] [Abstract][Full Text] [Related]
18. Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-beta-thalassemia in Northeast Thailand.
Nuntakarn L; Fucharoen S; Fucharoen G; Sanchaisuriya K; Jetsrisuparb A; Wiangnon S
Blood Cells Mol Dis; 2009; 42(1):32-5. PubMed ID: 18951049
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin Sabine [beta 91 (F7) Leu-->Pro]: occurrence in a Sardinian individual with hemolytic anemia and inclusion bodies.
Gasperini D; Galanello R; Melis MA; Iannelli S; Giordano P; Bernini LF; Cao A
Haematologica; 1992; 77(5):381-3. PubMed ID: 1336469
[TBL] [Abstract][Full Text] [Related]
20. [Dominant beta-thalassemia alleles in the Czech and Slovak population (beta-thalassemia mutations in 112(T-A) and 121(G-T) codons and the unstable Hradec Králové hemoglobin or alpha 2 beta 2 115 (G17) Ala-Asp)].
Indrák K; Divoký V; Brabec V; Chrobák L; Mociková K; Sakalová A; Svobodová M; Indráková J; Hammerová T; Zarnovicanová M
Vnitr Lek; 1994 Apr; 40(4):223-30. PubMed ID: 8184583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
